Ignite Creation Date:
2024-07-17 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06480240
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-06-18
Brief Title:
A Phase 12 Study of OBI-992 in Subjects With Advanced Solid Tumors
Sponsor:
OBI Pharma Inc
Organization:
OBI Pharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumor |
Keywords: